Medi-Cal Oncology Modifiers Explained: 26 vs TC, U7, and Brachytherapy Billing (C2616–Q3001)

You just billed a radiation oncology procedure the same way you’ve done it for three years. Two weeks later, the claim came back denied. “Incorrect modifier usage,” it says or worse: “Missing required documentation.”

Medi-Cal’s oncology billing rules are enforced through the DHCS provider manual and fee schedule updates that often take effect before practices receive notice. The denial codes that come back rarely tell you which specific rule you violated. Split billing with modifiers 26 and TC sounds simple until you hit edge cases. Modifier U7 exists in this weird compliance gray zone that confuses even veteran billers. And if you are billing brachytherapy source codes like C2616 or Q3001 without the right attachments, getting paid becomes nearly impossible.

The worst part? A lot of these denials are avoidable if you know exactly what Medi-Cal is looking for. This is a practical guide for California oncology and radiation therapy practices billing Medi-Cal for split services, repeat procedures, and radioactive source materials. So let’s cut through the confusion and talk about how to actually get these claims paid.

The Global vs Split Decision That Comes Before Modifiers 26 and TC

Before assigning modifier 26 or TC, answer three questions:

1. Does your practice own the imaging or treatment equipment, or does a hospital or imaging center own it?
2. Is there a written agreement between the professional and technical provider about who bills each component?
3. Does Medi-Cal have a contract that specifies billing requirements for your specific arrangement?

If your practice owns the equipment and the physician performs both supervision and interpretation at the same site: bill global.

If the physician interprets at a different location than where the equipment is housed: modifier 26 for the physician, TC for the facility.

If your practice contracts with a hospital that owns the equipment: the hospital bills TC, your practice bills 26.

This ownership and contractual structure is the decision that comes first. Modifier 26 and TC are just the labels that follow. Medi-Cal audits frequently target 26 and TC claims where the service location documentation does not support the split. Maintain a written record of your billing arrangement that survives a DHCS records request.

What Are Split-Billable Modifiers (And Why Does Medi-Cal Care)?

Most oncology and radiology procedures have two parts:

• the professional component (what the doctor does) and
• the technical component (the equipment, room, staff, and supplies)

When a hospital or imaging center bills for both, they use the base CPT code without modifiers. But when the professional and technical parts happen in different locations or are billed separately, you need modifiers 26 and TC.

Modifier 26 = Professional component only (physician’s interpretation, supervision, report writing)

Modifier TC = Technical component only (equipment use, technician time, supplies)

Pretty straightforward, except Medi-Cal doesn’t always reimburse these the way you’d expect.

Breaking Down the Reimbursement

The problem is that a lot of practices bill modifier 26 when they should be billing global, or they double-bill TC when the hospital already submitted it. Medi-Cal’s split billing rules are strict, and if there’s any overlap or missing documentation about where the service happened, you’re getting denied.

Always verify in your system whether the technical component was provided in-house or at an outside facility before assigning 26 or TC. If both happened under your roof, bill global.

The Modifier U7 Gray Area That Trips Up Most Billers

Modifier U7 is supposed to indicate when the same physician repeats a procedure on the same day for legitimate clinical reasons. Sounds useful, right?

Yeah, until you realize Medi-Cal has very specific ideas about when this modifier is actually appropriate, and most billers guess wrong.

When U7 Actually Makes Sense

U7 applies when:

• The same doctor performs the same imaging study or treatment twice in one day
• There is a documented reason it had to be repeated, like verifying brachytherapy seed placement or rechecking an unclear scan
• It is the same physician both times

If a different doctor does the repeat, that is modifier 77. If it is days apart, it is just a separate date of service with no modifier at all.

Common Ways This Goes Wrong

Here is the brutal truth about U7 and Medi-Cal. The payer does not give you the benefit of the doubt. If your documentation does not explicitly say “repeat procedure performed due to (specific clinical reason like motion artifact on initial images)” they will assume it is a billing error or that you are trying to double-bill and deny it.

U7 requires airtight documentation.

It needs to say exactly what went wrong with the first attempt or why clinical judgment required doing it again.

Brachytherapy Source Codes and the Invoice Attachment Rule

If you bill for radioactive seeds or sources (the actual physical materials used in brachytherapy), you’re dealing with codes like C2616, C2634, C2635, C2636, C2637, C2638, C2639, C2640, C2641, C2642, C2643, C2698, C2699, and Q3001.

These cover different isotopes. Iodine-125 seeds for prostate cancer, cesium-131 for brain tumors, yttrium-90 microspheres for liver cancer, and so on.

Here’s the thing nobody tells you upfront. Medi-Cal requires you to attach the vendor invoice to every single one of these claims. Not later if they ask. Not a summary you typed up. The actual invoice from the supplier.

Why Medi-Cal Requires This

Brachytherapy sources cost serious money. One iodine-125 seed runs $30 to $50, and you might implant 60 or 80 of them in a single procedure. Because these are buy-and-bill items (you purchase them, use them, then bill Medi-Cal for reimbursement), there’s fraud risk.

Without the invoice, Medi-Cal can’t verify:

• You actually bought the sources
• The quantity you’re billing matches what you purchased
• You’re not inflating the cost

CMS has similar rules for exactly this reason. These materials are too expensive and too easy to overbill without proof.

What Needs to Be On That Invoice

Miss even one of these and the claim comes back denied. And you cannot just send it in later as a supplemental document. Medi-Cal wants it attached the first time you submit.

How to Bill Brachytherapy Sources Without Getting Denied

1. Purchase the sources from an approved vendor (make sure you get an itemized invoice immediately, not just a packing slip)
2. Verify the HCPCS codes on the invoice match what you plan to bill (vendor coding errors happen more than you’d think)
3. Document the actual usage in the patient’s chart (if you ordered 50 seeds but only implanted 48, bill for 48)
4. Attach a clear, readable copy of the invoice to the electronic claim (PDF format, not a smartphone photo)
5. Submit the claim with the appropriate CPT code for the brachytherapy procedure (like 55875 for prostate seed implantation) plus the applicable C-code or Q3001 for the sources
6. Keep a copy of everything for at least 7 years (Medi-Cal can audit you retroactively)

If you’re submitting electronically and the invoice file is too large, split it or compress it. Never skip the attachment thinking you’ll send it “if they ask.” They won’t ask, they’ll just deny.

Source Codes You Will See Most Often

Be careful with C2698 and Q3001. These “not otherwise specified” codes get flagged more often because they are easy to misuse when a more specific code actually exists.

For yttrium-90 microsphere claims (C2616), verify whether Medi-Cal requires the National Drug Code on the claim in addition to the HCPCS code. NDC reporting requirements for drug-related brachytherapy codes have expanded and a missing NDC triggers the same denial as a missing invoice for some Medi-Cal plans.

Medi-Cal Managed Care vs Fee-for-Service Brachytherapy

The majority of Medi-Cal beneficiaries are enrolled in managed care plans rather than fee-for-service Medi-Cal. Prior authorization requirements for brachytherapy procedures vary by plan. Anthem Blue Cross Medi-Cal, Health Net Promise and Molina Healthcare each publish their own clinical criteria for brachytherapy coverage that may differ from DHCS fee-for-service rules. Before scheduling a brachytherapy procedure for a Medi-Cal managed care patient, verify authorization requirements with the specific plan. The invoice attachment rule applies to both fee-for-service and managed care claims, but the prior authorization process is plan specific.

What Actually Keeps These Claims From Getting Denied

Based on what actually happens in California oncology practices, here’s what keeps claims moving.

Before you hit submit!

• Confirm if the procedure is even split-billable (check the CPT book for “professional component” language)
• Figure out if you’re billing 26, TC, or global based on service location
• If you’re using U7, make absolutely sure the doctor’s note says “repeat procedure” and explains why
• For brachytherapy codes, verify the invoice is attached and the units match your claim exactly
• Check that the invoice has all six required elements (vendor details, HCPCS codes, quantity, unit cost, lot numbers, purchase date)
• Run it through your clearinghouse edits before final submission

After the claim goes out:

• Check claim status within 10 days (don’t wait for denial letters to show up)
• If it gets denied for “missing documentation,” resubmit as a corrected claim with everything attached again (Medi-Cal doesn’t always pull old attachments forward)
• Log every denial reason so you can spot patterns (if U7 keeps getting denied, your documentation process needs work)

Struggling With Modifier Denials?

Dastify’s compliance team reviews your claims before submission to catch these errors.

Get a free audit now

Appealing Medi-Cal Oncology Denials When They Still Happen

Even correct claims get denied in Medi-Cal. Here is the recovery path for each denial type. Modifier 26/TC denial (CO-4 or CO-97). If denied for incorrect modifier use, review the claim against the service location documentation. If the modifier was correct, appeal with a letter explaining the service arrangement (physician independent from facility, separate ownership) and attach any written agreement between professional and technical providers. Medi-Cal redetermination requests must be filed within 90 days of the remittance advice.

U7 denial (duplicate billing). Resubmit as a corrected claim with the physician’s note explicitly documenting the clinical reason for the repeat procedure attached. Do not appeal a U7 denial without the supporting documentation. It will be upheld. With documentation, Medi-Cal overturn rates on U7 appeals are high because the issue is almost always documentation, not clinical inappropriateness.

Brachytherapy source code denial (missing documentation). Resubmit as a corrected claim, not a new claim, with the complete invoice attached. Medi-Cal typically does not carry forward attachments from the original submission, so every resubmission needs the full invoice package. If denied for unit mismatch, attach both the invoice and the operative or procedure note documenting actual sources implanted.

DHCS audit response. If you receive a DHCS audit notice for oncology claims, engage a healthcare attorney or compliance consultant before responding. Extrapolation methodology means your response to an audit sample affects repayment calculation for your entire claim history.

What Happens When These Mistakes Become a Pattern

Medi-Cal doesn’t just deny problem claims and move on. If they notice a pattern (like consistently using U7 without documentation, or submitting brachytherapy claims without invoices), they can trigger a full audit.

California’s DHCS audit division has ramped up enforcement since 2023. When they find systematic errors, they:

• Demand repayment for all incorrect claims (sometimes going back 3 to 5 years)
• Use extrapolation (if they sample 50 claims and find errors in 10, they’ll assume a 20% error rate across everything and calculate your repayment that way)
• Flag your NPI for heightened review on every future claim

That’s not a scare tactic. That’s standard procedure when compliance breaks down.

Let Dastify Solutions handle your oncology billing so you never deal with this again.

Get in touch now!

To Sum It Up

Oncology billing in Medi-Cal is not something you can wing. Modifier 26 and TC split billing only works when you understand the ownership structure first and document the service location accurately. U7 only flies when your physician notes clearly explain why the repeat was necessary. Brachytherapy source codes absolutely require that vendor invoice attached, no exceptions.

Get these right and your claims go through clean. Get them wrong and you are stuck in appeal for months while revenue sits in limbo.